Clinical Trial: A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07919405) titled 'A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity' on Oct. 30.

Brief Summary: This study is testing whether CagriSema is safe and works well in adults with high blood pressure and excess body weight. Participants will receive CagriSema, semaglutide, cagrilintide, or placebo, and treatment will be assigned by chance. CagriSema and cagrilintide are investigational medicines, while semaglutide is already available by prescription.

Study Start Date: Nov. 11

Study Type: INTERVENTIONAL

Condition: Hypertension Obesity

Intervention: DRUG: Cag...